PB Ratio: 16.98

Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 16.98 is 174% above its estimated 1-year average of 6.19, near the high end of its estimated 1-year range (5.26–16.98).

As of 2026-10-06T14:17:20.456Z.

LIMN PB Ratio Metrics

P/B vs. estimated history

At 16.98, P/B is above its estimated 1-year median — higher than 100% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)

The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Liminatus Pharma, Inc. Class A Common Stock (LIMN)?

The P/B ratio for LIMN stock is 16.98.

Is Liminatus Pharma, Inc. Class A Common Stock's P/B ratio high or low?

The P/B ratio of 16.98 is 174% above its estimated 1-year average of 6.19, near the high end of its estimated 1-year range (5.26–16.98).

Related Metrics